Scholars Central

Conference abstractPublished 26 Aug 2020

Antioxidant and Antidiabetic activity of chalcone cb6 (E)-3-(4-Flourophenyl)-1-Phenylprop-2-en-1-one

Authors: Hafsa Iqbal

University of Agriculture Faisalabad, Pakistan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Diabetes is a metabolic disorder having serious consequence on health. The pharmacological treatment of diabetes mellitus may involve the use of medications as well as proper diet. Chalcones are flavonoid precursors and have shown a number of antioxidant properties. The current study was conducted to evaluate the antidiabetic and antioxidant activity of newly synthesized chalcone derivative cb6 (E)-3-(4-flourophenyl)-1-phenylprop-2-en-1-one. Hyperglycemia was induced by using alloxan monohydrate intraperitoneally (150mg/kg).In this study 50 albino wister rats were divided into 5 groups. First group was on normal routine diet; second group was given alloxan monohydtrate; group 3 was given glibenclamide; group 4 ( treated 1) was treated by using research compound at dose rate of 5ml/kg; group 5 ( treated 2) was given research compound at dose rate of 10ml/kg. Antidiabetic activity of chemical compound was determined by performing biochemical and istopathological analysis. Antidiabetic activity of chemical compound in comparison to the activty of synthetic drug glibenclamide was determined. The statistical analysis of variance (ANOA) was performed and the significance among different groups was determined by DMR ( Dunca Multiple Range) test. Results of study indicated that chalcone cb6 significantly reversed the alloxaninduced hyperglycemia by improving biochemical and oxidative stress parameters. Histopatological analysis also showed the antioxidant and antihyperglycemic potential of chalcone cb6. cb6 iproved the activity of endocrine tissues of pancreas by decreasing the oxidative stress by its free radcal scavenging activity

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • BylineArticles whose byline prints “Hafsa Iqbal”